CN101036714A - 一种治疗和/或预防糖尿病的药物组合物 - Google Patents
一种治疗和/或预防糖尿病的药物组合物 Download PDFInfo
- Publication number
- CN101036714A CN101036714A CN 200710107129 CN200710107129A CN101036714A CN 101036714 A CN101036714 A CN 101036714A CN 200710107129 CN200710107129 CN 200710107129 CN 200710107129 A CN200710107129 A CN 200710107129A CN 101036714 A CN101036714 A CN 101036714A
- Authority
- CN
- China
- Prior art keywords
- peoniflorin
- radix paeoniae
- jasminoidin
- fructus gardeniae
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | N | 空腹血糖(mmol/L) | 空腹胰岛素(mIU/L) | ||
给药前 | 给药后 | 给药前 | 给药后 | ||
空白组 | 9 | 3.9±0.7 | 3.9±0.3 | 16.7±5.4 | 15.2±4.1 |
格列本脲组 | 9 | 4.0±0.6 | 2.6±0.4** | 14.3±3.6 | 21.7±5.9* |
栀子A大剂量 | 9 | 4.1±0.7 | 3.3±0.6 | 13.3±2.4 | 19.1±3.4* |
栀子A中剂量 | 9 | 3.9±0.5 | 4.0±0.5 | 20.2±7.1 | 18.8±6.3 |
栀子A小剂量 | 9 | 4.0±0.7 | 3.9±0.6 | 21.7±5.4 | 23.2±7.9 |
栀子B大剂量 | 9 | 4.0±0.6 | 3.3±0.7 | 16.7±6.4 | 25.7±5.8* |
栀子B小剂量 | 9 | 4.1±0.7 | 4.2±0.8 | 13.5±2.1 | 15.8±4.2 |
芍药A大剂量 | 9 | 3.9±0.6 | 3.9±0.6 | 19.6±6.6 | 18.0±5.5 |
芍药A中剂量 | 9 | 4.1±0.7 | 4.0±0.6 | 15.7±5.7 | 17.8±6.8 |
芍药A小剂量 | 9 | 4.0±0.6 | 3.9±0.5 | 20.9±7.5 | 19.6±5.9 |
芍药B大剂量 | 9 | 4.1±0.5 | 4.1±0.6 | 14.1±3.1 | 15.7±5.0 |
芍药B小剂量 | 9 | 3.9±0.6 | 3.9±0.6 | 21.2±8.1 | 20.8±7.3 |
组合A大剂量 | 9 | 4.0±0.7 | 3.1±0.5 | 20.5±6.9 | 19.8±6.5 |
组合A中剂量 | 9 | 4.1±0.6 | 3.4±0.7 | 12.2±2.3 | 11.8±2.3 |
组合A小剂量 | 9 | 4.0±0.7 | 3.4±0.5 | 17.5±6.2 | 18.3±5.5 |
组合B大剂量 | 9 | 4.2±0.5 | 3.2±0.6 | 20.3±6.6 | 21.8±7.3 |
组合B小剂量 | 9 | 3.9±0.7 | 3.0±0.6 | 14.9±4.2 | 13.8±3.3 |
组别 | N | 空腹血糖(mmol/L) | 空腹胰岛素(mIU/L) | ||
给药前 | 给药后 | 给药前 | 给药后 | ||
空白组 | 8 | 17.8±2.0 | 15.6±2.3 | 9.7±3.4 | 9.2±3.1 |
二甲双胍组 | 8 | 17.6±1.9 | 10.9±2.1* | 9.3±2.6 | 11.7±2.5 |
栀子A极大剂量 | 8 | 17.3±1.7 | 11.8±1.5* | 8.6±2.7 | 13.7±2.5* |
栀子A大剂量 | 8 | 17.5±1.8 | 16.1±1.3 | 10.1±2.8 | 11.1±3.4 |
栀子A中剂量 | 8 | 17.4±1.6 | 15.5±2.0 | 9.2±2.3 | 10.8±3.1 |
栀子A小剂量 | 8 | 17.7±1.6 | 15.9±1.9 | 9.7±3.4 | 10.2±3.9 |
栀子B极大剂量 | 8 | 17.6±1.5 | 11.9±1.7* | 9.9±3.2 | 14.8±4.5* |
栀子B大剂量 | 8 | 17.4±1.5 | 16.1±1.7 | 10.2±1.9 | 10.2±2.8 |
栀子B中剂量 | 8 | 17.7±1.8 | 16.5±2.0 | 8.8±2.0 | 9.7±2.5 |
栀子B小剂量 | 8 | 17.6±1.6 | 16.0±1.4 | 9.5±2.7 | 9.8±1.2 |
芍药A极大剂量 | 8 | 17.8±1.5 | 11.8±1.7* | 9.6±2.8 | 10.7±3.5 |
芍药A大剂量 | 8 | 17.5±1.5 | 16.3±1.5 | 9.6±5.6 | 10.0±3.9 |
芍药A中剂量 | 8 | 17.6±1.8 | 15.9±1.3 | 8.7±2.7 | 9.8±4.8 |
芍药A小剂量 | 8 | 17.5±1.4 | 16.5±1.4 | 10.6±3.5 | 10.6±3.9 |
芍药B极大剂量 | 8 | 17.4±1.4 | 10.8±1.5** | 10.1±3.8 | 10.3±3.2 |
芍药B大剂量 | 8 | 17.7±2.1 | 16.6±2.0 | 9.1±3.1 | 9.7±3.0 |
芍药B中剂量 | 8 | 17.5±2.0 | 16.9±2.3 | 9.8±2.3 | 9.3±2.5 |
芍药B小剂量 | 8 | 17.8±1.9 | 16.2±2.1 | 9.9±2.4 | 9.2±2.0 |
组合A极大剂量 | 8 | 17.6±1.6 | 8.8±1.2** | 9.5±2.8 | 15.6±3.2* |
组合A大剂量 | 8 | 17.4±1.8 | 8.9±1.1** | 9.5±3.9 | 14.8±6.5* |
组合A中剂量 | 8 | 17.6±1.6 | 11.2±1.5** | 9.2±2.3 | 13.8±2.3* |
组合A小剂量 | 8 | 17.7±1.9 | 12.1±1.2* | 10.5±4.2 | 11.3±4.5 |
组合B极大剂量 | 8 | 17.3±1.2 | 8.2±1.2** | 9.8±3.3 | 14.7±3.3* |
组合B大剂量 | 8 | 17.6±1.8 | 8.5±1.2** | 10.2±2.4 | 14.8±3.9* |
组合B中剂量 | 8 | 17.5±2.2 | 11.0±1.5** | 9.9±2.9 | 14.3±2.1* |
组合B小剂量 | 8 | 17.7±2.0 | 11.9±2.5* | 8.9±1.2 | 9.8±2.0 |
组合C极大剂量 | 8 | 17.4±1.8 | 7.9±1.3** | 9.3±2.1 | 14.1±2.4* |
组合C大剂量 | 8 | 17.2±2.0 | 8.1±1.4** | 10.5±2.9 | 15.2±3.2* |
组合C中剂量 | 8 | 17.9±2.1 | 11.2±1.6** | 9.5±2.1 | 14.1±2.2* |
组合C小剂量 | 8 | 18.1±2.0 | 12.3±2.5* | 9.1±1.5 | 9.7±1.4 |
组别 | N | 空腹血糖(mmol/L) | 空腹胰岛素(mIU/L) | ||
给药前 | 给药后 | 给药前 | 给药后 | ||
正常组 | 8 | 4.1±0.6 | 4.3±0.3 | 17.7±4.4 | 16.2±4.5 |
空白组 | 8 | 10.8±1.1 | 9.6±1.3 | 33.7±5.4 | 36.2±6.1 |
罗格列酮组 | 8 | 11.6±1.3 | 5.1±2.1** | 35.3±6.6 | 18.7±5.5** |
栀子A极大剂量 | 8 | 11.3±1.1 | 6.3±0.9* | 36.6±5.9 | 33.4±5.5 |
栀子A大剂量 | 8 | 12.2±1.2 | 7.1±1.0* | 38.1±6.8 | 33.2±6.3 |
栀子A中剂量 | 8 | 10.4±0.6 | 9.5±1.3 | 29.2±4.3 | 28.8±3.1 |
栀子A小剂量 | 8 | 9.7±0.9 | 10.3±1.1 | 29.7±3.4 | 30.2±4.9 |
栀子B极大剂量 | 8 | 10.6±0.5 | 6.1±1.5* | 31.9±5.2 | 32.8±4.5 |
栀子B大剂量 | 8 | 9.4±0.5 | 5.3±0.7* | 33.2±6.9 | 35.2±7.8 |
栀子B中剂量 | 8 | 11.7±0.8 | 10.5±1.0 | 28.8±5.0 | 29.7±4.5 |
栀子B小剂量 | 8 | 10.6±0.6 | 10.0±0.4 | 29.5±4.7 | 29.8±3.2 |
芍药A极大剂量 | 8 | 9.8±0.5 | 5.8±0.6* | 38.6±5.7 | 21.4±4.5* |
芍药A大剂量 | 8 | 10.5±1.1 | 6.3±0.2* | 39.1±5.8 | 22.1±4.3* |
芍药A中剂量 | 8 | 10.6±0.8 | 6.2±0.4* | 32.7±4.7 | 21.8±3.8* |
芍药A小剂量 | 8 | 11.5±1.4 | 10.5±1.4 | 32.6±3.5 | 29.6±4.9 |
芍药B极大剂量 | 8 | 9.4±0.4 | 5.2±0.5* | 33.1±4.8 | 19.3±5.2* |
芍药B大剂量 | 8 | 10.7±1.1 | 6.2±1.0* | 29.8±5.1 | 18.2±4.0* |
芍药B中剂量 | 8 | 10.5±1.0 | 6.7±1.1* | 29.8±4.3 | 17.9±4.5* |
芍药B小剂量 | 8 | 9.8±0.9 | 10.2±0.3 | 30.9±5.4 | 29.8±6.0 |
组合A极大剂量 | 8 | 11.6±0.6 | 4.9±0.5** | 29.5±3.8 | 14.6±3.6** |
组合A大剂量 | 8 | 11.4±0.8 | 5.0±0.9** | 33.5±5.9 | 16.2±6.5** |
组合A中剂量 | 8 | 9.6±1.1 | 6.0±1.0* | 29.9±5.3 | 16.8±4.3* |
组合A小剂量 | 8 | 9.7±0.9 | 6.1±1.2* | 30.5±4.2 | 16.3±5.5* |
组合B极大剂量 | 8 | 9.3±0.5 | 4.2±0.2** | 32.8±6.3 | 15.7±4.3** |
组合B大剂量 | 8 | 10.6±0.8 | 5.5±0.2** | 30.2±4.4 | 15.9±5.9** |
组合B中剂量 | 8 | 10.9±1.2 | 6.0±0.7* | 29.9±3.9 | 15.3±4.3* |
组合B小剂量 | 8 | 11.7±2.0 | 6.5±0.5* | 31.9±6.2 | 16.8±5.4* |
组合C极大剂量 | 8 | 9.9±0.9 | 4.3±0.3** | 33.1±6.5 | 15.9±4.53** |
组合C大剂量 | 8 | 10.3±1.1 | 5.2±0.4** | 32.3±5.1 | 15.7±5.2** |
组合C中剂量 | 8 | 10.2±1.2 | 5.9±0.9* | 31.9±5.9 | 15.3±4.9* |
组合C小剂量 | 8 | 11.2±2.0 | 6.2±0.8* | 30.4±5.2 | 16.5±6.0* |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101071292A CN101036714B (zh) | 2007-05-08 | 2007-05-08 | 一种治疗和/或预防糖尿病的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101071292A CN101036714B (zh) | 2007-05-08 | 2007-05-08 | 一种治疗和/或预防糖尿病的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101036714A true CN101036714A (zh) | 2007-09-19 |
CN101036714B CN101036714B (zh) | 2010-06-02 |
Family
ID=38888022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101071292A Active CN101036714B (zh) | 2007-05-08 | 2007-05-08 | 一种治疗和/或预防糖尿病的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101036714B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113230334A (zh) * | 2021-03-04 | 2021-08-10 | 上海嫣蓉生物科技有限公司 | 一种中药提取物及其制备方法与应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100509010C (zh) * | 2005-04-25 | 2009-07-08 | 云南生物谷灯盏花药业有限公司 | 一种治疗心脑血管病的中药制剂及其制备方法 |
-
2007
- 2007-05-08 CN CN2007101071292A patent/CN101036714B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113230334A (zh) * | 2021-03-04 | 2021-08-10 | 上海嫣蓉生物科技有限公司 | 一种中药提取物及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101036714B (zh) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100345569C (zh) | 一种治疗糖尿病视网膜病变的药物及其制备方法 | |
CN1298363C (zh) | 一种辅助降血糖的保健食品及其制备方法 | |
CN1772261A (zh) | 一种治疗眼部发炎、病变及出血的口服药物及制备方法 | |
CN1726929A (zh) | 一种治疗糖尿病的药物组合物 | |
CN101028446A (zh) | 治疗症状性干眼的药物 | |
CN1799582A (zh) | 降血糖、降血压的药物 | |
CN102940800A (zh) | 治疗糖尿病的中药 | |
CN101036714B (zh) | 一种治疗和/或预防糖尿病的药物组合物 | |
CN1565524A (zh) | 一种治疗老年性痴呆的药物及其制备方法 | |
CN1248698C (zh) | 一种治疗冠心病或冠心病合并心功能不全的药物及其制备方法 | |
CN101032534A (zh) | 救必应总皂苷的制备方法及应用 | |
CN1548142A (zh) | 一种改善糖耐量和治疗糖尿病及肥胖症的药物及其制备方法 | |
CN1748771A (zh) | 一种治疗糖尿病的中药药物组合物及其制备方法和应用 | |
CN1857492A (zh) | 清泻制剂及新的制备方法 | |
CN1636581A (zh) | 一种红花药物组合物、其制备方法及其用途 | |
CN1689637A (zh) | 一种治疗心脑血管疾病的中药制剂及其制备方法 | |
CN101053598A (zh) | 一种防治心脑血管疾病及糖尿病的药物组合物 | |
CN108079000A (zh) | 一种治疗糖尿病的药物组合物及其制备方法 | |
CN1546143A (zh) | 一种补肾壮阳鹿阳强肾中药制剂及制备方法 | |
CN1682980A (zh) | 治疗糖尿病的药物及其制备方法 | |
CN1857368A (zh) | 一种治疗糖尿病的药物组合物 | |
CN1857293A (zh) | 一种含有野黄芩苷和芍药苷的药用组合物 | |
CN1218697C (zh) | 用于治疗或改善关节炎的药物组合物和饮食补充剂 | |
CN1244324C (zh) | 精氨酸对糖尿病皮肤组织“隐性损害”的改善作用 | |
CN1111426C (zh) | 一种治疗糖尿病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHENZHEN CITY JINSHA JIANG INVESTMENT CO., LTD. Free format text: FORMER NAME: SHENZHEN CITY BIOVALLEY TECHNOLOGY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 518026, A, building 34, block, Yitian Road, Futian District, Guangdong, Shenzhen Patentee after: Shenzhen Biovalley Technology Co., Ltd. Address before: 518026, A, building 34, block, Yitian Road, Futian District, Guangdong, Shenzhen Patentee before: Shengwugu Science and Technology Co., Ltd., Shenzhen City |
|
ASS | Succession or assignment of patent right |
Owner name: YUNNAN BIOVALLEY PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHENZHEN JINSHAJIANG INVESTMENT CO., LTD. Effective date: 20130523 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 518026 SHENZHEN, GUANGDONG PROVINCE TO: 650224 KUNMING, YUNNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130523 Address after: 650224 University Science Park, hi tech Industrial Development Zone, Yunnan, Kunming Patentee after: YUNNAN BIOVALLEY PHARMACEUTICAL CO., LTD. Address before: 518026, A, building 34, block, Yitian Road, Futian District, Guangdong, Shenzhen Patentee before: Shenzhen Biovalley Technology Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Lin Gufeng Document name: Notification of Passing Examination on Formalities |